Belluscura gets seal of approval from MAC
By HME News Staff
Updated 10:45 AM CST, Tue November 30, 2021
LONDON and PLANO, Texas – Belluscura has announced that Palmetto GBA, a DME Medicare Administrative Contractor, has issued a final local coverage determination for the X-PLOR2R portable oxygen concentrator. The company estimates that Medicare reimbursement covers about 50% of the oxygen concentrator market in the United States and, therefore, the MAC’s seal of approval will have a positive impact on its financials. “Receiving the two Medicare reimbursement codes should further expand access and the use and distribution of the X-PLOR2R throughout the U.S.,” said Robert Rauker, CEO. “We believe many Medicare patients will ask their health care providers and DME providers to issue them the lightweight X-PLOR2R.” Belluscura says the X-PLOR2R, weighing only 3.25 pounds, is the world’s first portable modular oxygen concentrator. The product won the Providers’ Choice Gold Award at Medtrade East in Atlanta in October.
Comments